Edge Wealth Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Edge Wealth Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-900	Closed	-$46K	–	588
2017 Q4	$46K	Buy	+900	New	+$64.7K	0.01%	230
2016 Q4	–	Sell	-600	Closed	-$36K	–	540
2016 Q3	$36K	Hold	600	–	–	0.02%	205
2016 Q2	$31K	Hold	600	–	–	0.01%	211
2016 Q1	$18K	Sell	600 -400	-40%	-$12.6K	0.01%	244
2015 Q4	$46K	Buy	1,000 +800	+400%	+$41.9K	0.02%	197
2015 Q3	$8K	Hold	200	–	–	﹤0.01%	318
2015 Q2	$12K	Sell	200 -600	-75%	-$39.7K	﹤0.01%	292
2015 Q1	$62K	Buy	+800	New	+$46.1K	0.02%	174

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Edge Wealth Management's ONCE Position: Q1 2018 in Review

Edge Wealth Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2018, closing a stake of 900 shares — an estimated $46K sold.

Edge Wealth Management first reported a position in ONCE in Q1 2015 and held it in 8 quarters. The position peaked at $62K in Q1 2015. 162 funds tracked by Wall St. Rank hold ONCE as of Q1 2018.

Edge Wealth Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Edge Wealth Management sold 900 Spark Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $46K.
Edge Wealth Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 8 quarters.
Edge Wealth Management's Spark Therapeutics, Inc. Common Stock position peaked at $62K in Q1 2015.
162 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Edge Wealth Management's 13F filing for Q1 2018, filed 5 Apr 2018.